Piper Jaffray Starts Avalanche Biotechnologies (AAVL) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- S&P 500, Nasdaq futures decline as US-Iran escalation rattles sentiment
- Oil gains over 2% as fresh military strikes threaten Hormuz shipments
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Apple sues OpenAI, two former employees for trade secrets theft
William Blair Starts Avalanche Biotechnologies (AAVL) at Outperform
August 25, 2014 7:12 AM EDTWilliam Blair initiated coverage on Avalanche Biotechnologies (NASDAQ: AAVL) with an Outperform rating.
For an analyst ratings summary and ratings history on Avalanche Biotechnologies click here. For more ratings news on Avalanche Biotechnologies click here.
Shares of Avalanche Biotechnologies closed at $30.52 yesterday.
... MoreCowen Starts Avalanche Biotechnologies (AAVL) at Outperform
August 25, 2014 7:11 AM EDTCowen initiated coverage on Avalanche Biotechnologies (NASDAQ: AAVL) with an Outperform rating and a price target of $45.00.
For an analyst ratings summary and ratings history on Avalanche Biotechnologies click here. For more ratings news on Avalanche Biotechnologies click here.
Shares of Avalanche Biotechnologies closed at $30.52 yesterday.
... MoreJefferies Starts Avalanche Biotechnologies (AAVL) at Buy
August 25, 2014 6:55 AM EDTJefferies initiates coverage on July IPO Avalanche Biotechnologies (NASDAQ: AAVL) with a Buy rating and a price target of $40.00.
Analyst Biren Amin said, "AAVL shares hold significant promise based on PI data with AVA-101 observing meaningful VA improvements and durable responses in wAMD... More
